{"disease":{"id":"eaton-lambert-syndrome","name":"Eaton-Lambert syndrome","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"amifampridine","indication_name":"Eaton-Lambert syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Firdapse","generic_name":"AMIFAMPRIDINE","company_name":"Catalyst Pharms","drug_phase":"marketed","molecular_target":"Voltage-gated potassium channel","drug_class":"Potassium Channel Blocker","quality_score":59,"revenue":"400","mechanism":"Firdapse works by blocking potassium channels in the nervous system, allowing more nerve impulses to be transmitted."},{"drug_id":"guanidine","indication_name":"Eaton-Lambert syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Guanidin","generic_name":"GUANIDINE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Voltage-gated potassium channel","drug_class":"Acetylcholine Releasing Agent","quality_score":24,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}